Enter assignee name

EPO Patents = 3

Forward Citations = 174

Loading Chart...

11 inventors (with patents filed for the assignee):

Guy Boileau (5 out of 10 patents)

Philippe Crine (4 out of 11 patents)

Isabelle Lemire (4 out of 7 patents)

4. Thomas P Loisel (2 out of 7 patents)

5. Denis Gravel (2 out of 15 patents)

6. Christian Lanctot (2 out of 3 patents)

7. Pierre Moffatt (2 out of 2 patents)

8. Elaref S Ratemi (2 out of 2 patents)

9. Mostafa Hatam (2 out of 2 patents)

10. Gethin Thomas (1 out of 1 patent)

11. Patrick Salois (1 out of 2 patents)

12. Pierre Leonard (2 patents)

13. Robert Heft (1 patent)

14. Hal Landy (0 patent)

15. Christian Lanctot (0 patent)

7 patents: Sort by Forward Citations

1. 7960529 - Bone delivery conjugates and method of using same to target proteins to bone (2011-06-14),

2. 7763712 - Bone delivery conjugates and method of using same to target proteins to bone (2010-07-27),

3. 7470668 - Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof (2008-12-30),

4. 7425531 - Bone polypeptide-1 (2008-09-16),

5. 7399466 - Method and compositions for promoting osteogenesis (2008-07-15),

6. 7365091 - Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX (2008-04-29),

7. 7105539 - Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex (2006-09-12),

Enobia Pharma Inc. is a biotechnology company specializing in developing and commercializing innovative therapies for rare genetic bone disorders. With a focus on improving the lives of patients through groundbreaking research and development, Enobia is dedicated to addressing unmet medical needs in the field of rare diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#135 in Montreal

#2,027 in Canada

Montreal, Canada

Enobia Pharma Inc.